KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Invested Capital (2016 - 2026)

Medpace Holdings filings provide 12 years of Invested Capital readings, the most recent being $598.3 million for Q1 2026.

  • On a quarterly basis, Invested Capital rose 0.79% to $598.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $598.3 million, a 0.79% increase, with the full-year FY2025 number at $459.1 million, down 44.39% from a year prior.
  • Invested Capital hit $598.3 million in Q1 2026 for Medpace Holdings, up from $459.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $881.4 million in Q3 2024 to a low of $172.4 million in Q2 2025.
  • Median Invested Capital over the past 5 years was $533.0 million (2022), compared with a mean of $544.8 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 87.18% in 2024 and later crashed 77.43% in 2025.
  • Medpace Holdings' Invested Capital stood at $436.4 million in 2022, then grew by 28.09% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then tumbled by 44.39% to $459.1 million in 2025, then surged by 30.33% to $598.3 million in 2026.
  • The last three reported values for Invested Capital were $598.3 million (Q1 2026), $459.1 million (Q4 2025), and $293.6 million (Q3 2025) per Business Quant data.